For Cryan Out Loud

Fly Charts: Deutsche Bank Doldrums and Exxon's Mixed Message

From pharma investors' tax obsession to shored-up Sony, here are four charts that tell you what you need to know in business today.
Photographer: Krisztian Bocsi/Bloomberg
At Closing, February 22nd
13.34 EUR
At Closing, February 22rd
75.86 USD

Good morning! This is Fly Charts, the daily charts-only newsletter from Gadfly; sign up here. From tax obsession to shored-up Sony, here are four charts that tell you what you need to know in business today.

Tax Great

Pharma investors' tax rate obsession has made for a very strange earnings week.

Source: Bloomberg/filings

Non-GAAP forecasts; intraday share price performance for Amgen and Merck; only includes companies that reported earnings after AbbVie

Better Balance

Kazuo Hirai's greatest legacy as he leaves Sony isn't its revamped TV business, but the company's increasingly strong balance sheet.

Source: Sony, Bloomberg Gadfly

Note: Howard Stringer became CEO in June 2005; Kazuo Hirai in April 2012; Kenichiro Yoshida will take over April 1.

Standout Business

Deutsche Bank is a solid business -- if you just remove the whole banking part.

Source: company filings

Note: data refer to FY 2017

Home Discomforts

Exxon needs better performance from and better messaging about its U.S. business.

Source: Bloomberg, the companies

Note: Net income for U.S. upstream divisions.

And don't miss Brooke Sutherland on the holiday America needs: "If Corporate America is opening up its wallet, we might as well get something worthwhile and lasting out of it, like a day off after the Super Bowl. Unless, of course, you were a recent contestant on Jeopardy, in which case you probably have no idea what I'm talking about. "

This column does not necessarily reflect the opinion of Bloomberg LP and its owners.

    To contact the author of this story:
    Max Nisen in New York at

    To contact the editor responsible for this story:
    Beth Williams at

    Before it's here, it's on the Bloomberg Terminal.